CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | HOLSTEIN ROGER C Director | Grant or award | +6,792 | 28,729 | ||
| 2026-05-21 | HOLSTEIN ROGER C Director | Grant or award · Stock Option (Right to Buy) | +4,003 | $12.49 | $50K | 4,003 |
| 2026-05-21 | HOLSTEIN ROGER C Director | Grant or award · Stock Option (Right to Buy) | +29,289 | 29,289 | ||
| 2026-05-21 | Park Jeffrey G Director | Grant or award | +7,924 | 39,981 | ||
| 2026-05-21 | Park Jeffrey G Director | Grant or award · Stock Option (Right to Buy) | +5,205 | $12.49 | $65K | 5,205 |
| 2026-05-21 | Park Jeffrey G Director | Grant or award · Stock Option (Right to Buy) | +31,458 | 31,458 | ||
| 2026-05-21 | Payson Norman Director | Grant or award | +5,660 | 12,349 | ||
| 2026-05-21 | Payson Norman Director | Grant or award · Stock Option (Right to Buy) | +3,203 | $12.49 | $40K | 3,203 |
| 2026-05-21 | Payson Norman Director | Grant or award · Stock Option (Right to Buy) | +27,119 | 27,119 | ||
| 2026-05-21 | Scott Cheryl Director | Grant or award | +5,660 | 19,772 | ||
| 2026-05-21 | Scott Cheryl Director | Grant or award · Stock Option (Right to Buy) | +27,119 | 27,119 | ||
| 2026-05-21 | MORRIS DEBRA L Director | Grant or award | +5,660 | 5,660 | ||
| 2026-05-21 | MORRIS DEBRA L Director | Grant or award · Stock Option (Right to Buy) | +3,203 | $12.49 | $40K | 3,203 |
| 2026-05-21 | MORRIS DEBRA L Director | Grant or award · Stock Option (Right to Buy) | +27,119 | 27,119 | ||
| 2026-05-20 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8,275 | $25.50 | $211K | 79,063 |
| 2026-05-19 | Cummings Melissa B Chief Operating Officer | Sale 10b5-1 | −9,578 | $25.00 | $239K | 73,371 |
| 2026-04-14 | Cummings Melissa B Chief Operating Officer | Shares withheld for taxes | −4,172 | $16.98 | $71K | 82,949 |
| 2026-03-17 | Clapp Geoffrey Chief Product Officer | Shares withheld for taxes | −3,275 | $17.42 | $57K | 60,647 |
| 2026-03-04 | Swartz Allison EVP, GC | Shares withheld for taxes 10b5-1 | −339 | $17.52 | $6K | 89,540 |
| 2026-03-04 | Swartz Allison EVP, GC | Sale 10b5-1 | −599 | $17.54 | $11K | 88,941 |
Page 5 of 25 · 499 trades